The In Vitro Permeability Study of Valsartan through Excised Rat Skin

Main Article Content

C. J. Mbah
C. O. Nnadi

Abstract

The in vitro permeability of valsartan through excised rat skin was investigated using Franz-type diffusion cells. The permeation was assessed by studying the effect of water, polysorbate-80 and eucalyptus oil on the permeability flux of valsartan through excised rat skin. The slope of linear portion of the graph obtained by plotting the cumulative amount of valsartan permeated per unit skin surface area as a function of time provided the permeability flux. Of the vehicles studied, only 6.0 % w/v polysorbate-80 solution provided most permeation of valsartan through the rat skin as evidenced by the highest permeability coefficient of valsartan.

Downloads

Download data is not yet available.

Article Details

How to Cite
Mbah, C. J., & Nnadi, C. O. (2025). The In Vitro Permeability Study of Valsartan through Excised Rat Skin. Journal of Biological Research and Biotechnology, 8(1), 598– 601. https://doi.org/10.4314/br.v8i1.62540
Section
Articles

References

Bhatia, K.S., Goa S, Freeman, T.P., Singh, J., (1997). Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J. Pharm. Sci. 86; 1011-1015.

Bisset, D.I., McBride, J.F., (1983).The use of domestic pig as an animal model of human dry skin for comparison of drug and normal skin properties. J. Soc. Cosmet. Chem. 34; 317-326.

Catz, P., Heller, J., (1989). Simple alkylesters as skin permeation enhancers. J. Control. Rel. 9; 33-41.

Doshi, U., Chien, Y.W., (1989). Alkanols and alkanoic acids as skin permeation enhancers for estrogens and androgens. Pharm. Res. 6; 167-170.

Flesch, G., Muller, P., Lloyd, P (1997). Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist in man. Eur. J. Clin. Pharmacol. 51; 15-120.

Flynn, G., Yalkowsky, S.H, Roseman, T.J., (1974). Mass transport phenomenon and models : theoretical concepts. J. Pharm. Sci. 63; 479-510.

Hwang, C.C., Danti, A.G., (1983). Percutaneous absorption of flufenamic acid in rabbits. Effects of dimethylsulfoxide and various nonionic surface active agents. J. Pharm. Sci. 72; 857-860.

Julreht, K., Keith, A.P., James, A.W., (1998). Development of a transdermal delivery device for melatoin in vitro studies. Drug. Dev. Ind. Pharm. 21; 1377-1387.

Latif, F., Tandon, S., Obeleniene, R., Hankins, S.R., Berlowitz, M.S., Ennezat, P.V., Le Jemtel, T.H (2001). Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan I healthy nomotensive subjects. J. Card. Fail. 7; 265-268.

Mbah, C.J., (2006) Solubilization of valsartan by aqueous glycerol, polyethylene glycol and micellar solutions. Pharmazie 61; 322-324.

Montenegro, L., Carbone, C., Giannone, I., Puglisi, G., (2007).Use of solid phase extraction to evaluate in vitro skin permeation of aescin. Pharmazie 62; 342-345.

Monti, D., Chatoni, P., Burgalessi, S., Najarro, M., Saettone, M., Boldrin, E., (2002). Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int. J. Pharm. 237; 209-214.

Priborsky, J., Takayama, K., Nagai, T., Waitzova, D., Elis, J.C., (1987). Evaluation of in vitro and in situ transdermal absorption of drugs in pig and rat skin. Chem. Pharm. Bull. (Tokyo) 35; 4915-4920.

Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Shafiq, S., (2008). Skin permeation mechanism and bioavailabilty enhancement of celecoxib from transdermally applied nanoemulsion. J. Nanotechnology 6; 3155-3168.

Shen, W.W., Danti, A.G., Bruscato, F.N., (1976). Effect of nonionic surfactants on percutaneous absorption of salicyclic acid and sodium salicyclate in the presence of dimethylsulfoxide. J. Pharm. Sci 65; 1780-1783.

Stoughton, R.B., Fritsch, W., (1964). The influence of dimethylsulfoxide on human percutaneous absorption. Arch. Dermatol 90; 512-517.

Toniton, E., (1986). Transdermal delivery of anxiolytics. In vitro skin permeation of midazolam maleate and diazepam. Int. J. Pharm. 33; 37-43.

Warster, D.E., Kramer, S.F., (1961). Investigation of some factors influencing percutaneous absorption. J. Pharm. Sci. 50; 288-293.

Watkinson, A.C., Hadgraft, J., Bye, A., (1991). Aspects of the transdermal delivery on postanglandins. Int. J. Pharm. 74; 229-236.

Williams, A.C., Barry, B.W., (1994). Terpenes and lipid-protein partitioning theory of skin penetration enhancement. Pharm. Res. 8; 17-24

Similar Articles

You may also start an advanced similarity search for this article.